Status:
ENROLLING_BY_INVITATION
Proactive Population Health Management of Cardiovascular Disease in Primary Care Using the PROSPERA-program.
Lead Sponsor:
Leiden University Medical Center
Collaborating Sponsors:
UMC Utrecht
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
The PROSPERA-program is a complex multilevel approach that includes training for healthcare providers, a risk assessment process, and decision support tools to help match patients with the appropriate...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age \> 40 years and ≤ 90 years
- Patient in a primary care practice enrolled in this study
- Included in the cardiovascular disease (CVD), increased vascular risk (IVR) or diabetes mellitus (DM) Dutch Integrated Care programs
- Additional criteria for subgroup that receives questionnaires: able to communicate in the Dutch and/or English language
- Exclusion Criteria:
- Patients with Diabetes Mellitus type I
- Patients receiving palliative care
- Patients with any form of cognitive impairment diseases such as Dementia or Alzheimer
- Patients who are treated in other Integrated Care programs because of their frailty (e.g. elderly who are treated in the 'Kwetsbare Ouderen Chronische Zorgprogramma')
Exclusion
Key Trial Info
Start Date :
February 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 9 2026
Estimated Enrollment :
848 Patients enrolled
Trial Details
Trial ID
NCT06593704
Start Date
February 17 2025
End Date
July 9 2026
Last Update
July 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Public Health and Primary Care
The Hague, South Holland, Netherlands, 2511PL